125 related articles for article (PubMed ID: 8537164)
1. Finasteride inhibits 5 alpha-reductase activity in human dermal fibroblasts: prediction of its therapeutic application in androgen-related skin diseases.
Nguyen QH; Chen T; Wang X; Chen Y; Chien P
Int J Dermatol; 1995 Oct; 34(10):720-5. PubMed ID: 8537164
[TBL] [Abstract][Full Text] [Related]
2. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
Chen W; Zouboulis CC; Orfanos CE
Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
[TBL] [Abstract][Full Text] [Related]
3. Effects of the anti-androgen finasteride on 5 alpha-reduction of androgens in the presence of progesterone in human gingival fibroblasts: modulatory actions of the alkaline phosphatase inhibitor levamisole.
Tilakaratne A; Soory M
J Periodontal Res; 2000 Aug; 35(4):179-85. PubMed ID: 10983877
[TBL] [Abstract][Full Text] [Related]
4. Effects of the anti-androgen finasteride on 5alpha-reductase activity in human gingival fibroblasts in response to minocycline.
Soory M; Virdi H
J Clin Periodontol; 1998 Jan; 25(1):67-73. PubMed ID: 9477022
[TBL] [Abstract][Full Text] [Related]
5. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
Imada S; Akaza H; Ami Y; Koiso K; Ideyama Y; Takenaka T
Eur Urol; 1997; 31(3):360-4. PubMed ID: 9129932
[TBL] [Abstract][Full Text] [Related]
6. The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride.
Soory M; Tilakaratne A
Arch Oral Biol; 2000 Apr; 45(4):257-65. PubMed ID: 10708666
[TBL] [Abstract][Full Text] [Related]
7. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
8. Anti-androgens and estrogens: modulators of VEGF expression in cultured hair dermal papilla cells.
Lachgar S; Charveron M; Sarraute J; Gall Y; Bonafe JL
Exp Dermatol; 1999 Aug; 8(4):336-8. PubMed ID: 10439259
[No Abstract] [Full Text] [Related]
9. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
[TBL] [Abstract][Full Text] [Related]
10. 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E; Flores E
Proc West Pharmacol Soc; 2002; 45():164-5. PubMed ID: 12434569
[TBL] [Abstract][Full Text] [Related]
11. Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.
Tilakaratne A; Soory M
Arch Oral Biol; 2001 Feb; 46(2):109-15. PubMed ID: 11163318
[TBL] [Abstract][Full Text] [Related]
12. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin-mediated androgen metabolism in gingival fibroblasts. Effects of the antiandrogen finasteride and the alkaline phosphatase inhibitor levamisole.
Soory M; Suchak A
J Clin Periodontol; 2002 Oct; 29(10):955-60. PubMed ID: 12445228
[TBL] [Abstract][Full Text] [Related]
14. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
15. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
16. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
[TBL] [Abstract][Full Text] [Related]
17. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal therapy for benign prostatic hyperplasia].
Sakai H; Kanetake H
Nihon Rinsho; 2002 Dec; 60 Suppl 11():358-61. PubMed ID: 12599600
[No Abstract] [Full Text] [Related]
19. Finasteride--an update and review.
Cather JC; Lane D; Heaphy MR; Nelson BR
Cutis; 1999 Sep; 64(3):167-72. PubMed ID: 10500917
[No Abstract] [Full Text] [Related]
20. Testosterone stimulates proliferation and inhibits interleukin-6 production of normal and hereditary gingival fibromatosis fibroblasts.
Coletta RD; Reynolds MA; Martelli-Junior H; Graner E; Almeida OP; Sauk JJ
Oral Microbiol Immunol; 2002 Jun; 17(3):186-92. PubMed ID: 12030972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
